Eflornithine Cream: Slowing Facial Hair Growth
SaveEflornithine is a prescription cream that slows facial hair growth but does not remove existing hair, so it is used alongside shaving, waxing, or laser. It works only on the skin where it is applied, not on hormones, so the benefit fades within about two months after stopping.
Last updated: July 2026
Talk to a clinician
A primary-care clinician
Gale can help you find one in your state and request a visit.
Find care →What is eflornithine cream?
Eflornithine is a prescription topical cream used to slow the growth of unwanted facial hair. According to the Endocrine Society guideline, it is an option for reducing facial hair, typically added to a hair-removal routine rather than used on its own 1Ref 1Martin KA, et al. (Endocrine Society) (2018).Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline.Endocrine Society hirsutism guideline: recommends topical eflornithine to slow facial hair growth, used as an adjunct to hair-removal methods, and notes that hirsutism treatments require at least 6 months to assess.. The cream works locally in the skin, slowing how quickly hair grows in the treated area; it does not pull out or dissolve hair that is already there. That distinction matters, because it sets realistic expectations: eflornithine changes the pace of regrowth, not the hair you can see today. It also does not touch hormone levels, so it addresses the symptom rather than any underlying cause. Understanding that distinction up front is what keeps expectations realistic and the plan sensible.
Does eflornithine actually work?
Eflornithine does help many people, but the benefit is best described as slower, finer growth rather than smooth skin. In clinical use, slower growth often becomes noticeable within about 8 weeks of steady twice-daily application, and results range from modest to meaningful from one person to the next. The Endocrine Society guideline positions it as an adjunct — most useful paired with laser hair removal, plucking, or waxing — because the combination outperforms either approach alone 1Ref 1Martin KA, et al. (Endocrine Society) (2018).Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline.Endocrine Society hirsutism guideline: recommends topical eflornithine to slow facial hair growth, used as an adjunct to hair-removal methods, and notes that hirsutism treatments require at least 6 months to assess.. Because it only slows growth, hair returns to its former pace once the cream is stopped, usually within a couple of months. Steady, ongoing use is what keeps the effect.
How is it used, and what results are realistic?
Eflornithine is applied in a thin layer to the affected area of the face twice a day, with several hours left between applications and before washing the area. Realistic results mean less frequent shaving or plucking and softer regrowth, not the permanent reduction that laser or electrolysis can offer over time. The Endocrine Society guideline frames hirsutism care as gradual, noting that any treatment needs at least 6 months of consistent use before its effect is judged fairly 1Ref 1Martin KA, et al. (Endocrine Society) (2018).Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline.Endocrine Society hirsutism guideline: recommends topical eflornithine to slow facial hair growth, used as an adjunct to hair-removal methods, and notes that hirsutism treatments require at least 6 months to assess.. Setting that expectation up front prevents disappointment at week two. Many people find the cream most satisfying when it is paired with a longer-term removal method that reduces the underlying hair. Consistency, more than any single application, is what determines the result over time.
What are the side effects and limits?
Side effects are usually mild and confined to the skin where the cream is applied — temporary stinging, redness, tingling, or occasional bumps from ingrown hairs. The bigger limit is conceptual: eflornithine manages a symptom and does nothing about why the hair is growing. When excess hair reflects a hormone condition such as polycystic ovary syndrome — which affects an estimated 6 to 12 percent of women of reproductive age, according to the Office on Women's Health — that cause still deserves its own workup 2Ref 2Office on Women's Health (U.S. HHS) (2025).Polycystic ovary syndrome.Office on Women's Health: PCOS, affecting an estimated 6 to 12 percent of reproductive-age women, is a common hormonal cause of excess facial hair that warrants its own evaluation.. The ACOG practice bulletin describes hormone-directed options, and our overviews of PCOS symptoms and PCOS-related hair changes explain how those pieces fit 3Ref 3American College of Obstetricians and Gynecologists (2018).ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome.ACOG Practice Bulletin No. 194: describes hormone-directed options for managing hirsutism and hyperandrogenism in PCOS.. The cream and a cause-directed plan can run together.
When facial hair growth needs a dermatologist
A primary care clinician or dermatologist can decide whether eflornithine fits your skin and goals and can pair it with the right removal method or medication. A visit is also a chance to check whether the hair growth signals an underlying condition worth testing, especially if it is spreading or arriving with irregular periods. Because the cream slows rather than removes hair and works only while it is used, it tends to suit people who want a steady, low-effort add-on to what they already do. Knowing what it can and cannot do makes the decision straightforward, and a brief conversation can settle whether it is worth trying for you.
Common questions
Related
Hormonal health
Sudden Facial Hair Growth: When to Get CheckedHormonal health
Hirsutism Workup: The Tests Behind the DiagnosisHormonal health
OTC Progesterone Cream: What Evidence Supports
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
Talk to a clinician
A primary-care clinician
Gale can help you find one in your state and request a visit.
Find care →Using eflornithine cream safely
- —Severe redness, burning, swelling, or a rash where the cream is applied is a reason to seek clinician review
- —No change in hair growth after several months of consistent use is a reason to seek clinician review
- —Facial hair that keeps spreading despite treatment is a reason to seek clinician review
- —Excess hair arriving with irregular periods or rapid masculine changes is a reason to seek clinician review
This article is general health education, not a prescription or medical advice. Whether eflornithine fits you is decided with a primary care clinician or dermatologist.
References
- 1.Martin KA, et al. (Endocrine Society) (2018). Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. doi:10.1210/jc.2018-00241 ✓Endocrine Society hirsutism guideline: recommends topical eflornithine to slow facial hair growth, used as an adjunct to hair-removal methods, and notes that hirsutism treatments require at least 6 months to assess.
- 2.Office on Women's Health (U.S. HHS) (2025). Polycystic ovary syndrome. Office on Women's Health (womenshealth.gov), U.S. HHS. link ✓Office on Women's Health: PCOS, affecting an estimated 6 to 12 percent of reproductive-age women, is a common hormonal cause of excess facial hair that warrants its own evaluation.
- 3.American College of Obstetricians and Gynecologists (2018). ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000002656 ✓ACOG Practice Bulletin No. 194: describes hormone-directed options for managing hirsutism and hyperandrogenism in PCOS.
3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy